| abstract |
The present invention relates to a tablet for preventing or treating angiogenesis or matrix metalloproteinase (MMP) activity mediated diseases, including melissa leaf extract, which has rosemary acid, caffeic acid, and rutin as the main active ingredients. Tablets have an excellent dissolution rate of 80% or more within 30 minutes of rosemary acid or caffeic acid, and stable in accelerated conditions, and thus may be useful for preventing or treating angiogenesis or MMP activity mediated diseases, especially obesity. |